Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.
Menon BK, Buck BH, Singh N, Deschaintre Y, Almekhlafi MA, Coutts SB, Thirunavukkarasu S, Khosravani H, Appireddy R, Moreau F, Gubitz G, Tkach A, Catanese L, Dowlatshahi D, Medvedev G, Mandzia J, Pikula A, Shankar J, Williams H, Field TS, Manosalva A, Siddiqui M, Zafar A, Imoukhuede O, Hunter G, Demchuk AM, Mishra S, Gioia LC, Jalini S, Cayer C, Phillips S, Elamin E, Shoamanesh A, Subramaniam S, Kate M, Jacquin G, Camden MC, Benali F, Alhabli I, Bala F, Horn M, Stotts G, Hill MD, Gladstone DJ, Poppe A, Sehgal A, Zhang Q, Lethebe BC, Doram C, Ademola A, Shamy M, Kenney C, Sajobi TT, Swartz RH; AcT Trial Investigators. Menon BK, et al. Among authors: alhabli i. Lancet. 2022 Jul 16;400(10347):161-169. doi: 10.1016/S0140-6736(22)01054-6. Epub 2022 Jun 29. Lancet. 2022. PMID: 35779553 Clinical Trial.
Safety and Efficacy of Tenecteplase Compared With Alteplase in Patients With Large Vessel Occlusion Stroke: A Prespecified Secondary Analysis of the ACT Randomized Clinical Trial.
Bala F, Singh N, Buck B, Ademola A, Coutts SB, Deschaintre Y, Khosravani H, Appireddy R, Moreau F, Phillips S, Gubitz G, Tkach A, Catanese L, Dowlatshahi D, Medvedev G, Mandzia J, Pikula A, Shankar JJ, Williams H, Field TS, Manosalva Alzate A, Siddiqui M, Zafar A, Imoukhoude O, Hunter G, Alhabli I, Benali F, Horn M, Hill MD, Shamy M, Sajobi TT, Swartz RH, Menon BK, Almekhlafi M. Bala F, et al. Among authors: alhabli i. JAMA Neurol. 2023 Aug 1;80(8):824-832. doi: 10.1001/jamaneurol.2023.2094. JAMA Neurol. 2023. PMID: 37428494 Free PMC article. Clinical Trial.
Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous Thrombosis.
Field TS, Dizonno V, Almekhlafi MA, Bala F, Alhabli I, Wong H, Norena M, Villaluna MK, King-Azote P, Ratnaweera N, Mancini S, Van Gaal SC, Wilson LK, Graham BR, Sposato LA, Blacquiere D, Dewar BM, Boulos MI, Buck BH, Odier C, Perera KS, Pikula A, Tkach A, Medvedev G, Canfield C, Mortenson WB, Nadeau JO, Alshimemeri S, Benavente OR, Demchuk AM, Dowlatshahi D, Lanthier S, Lee AYY, Mandzia J, Suryanarayan D, Weitz JI, Hill MD; SECRET Investigators. Field TS, et al. Among authors: alhabli i. Stroke. 2023 Nov;54(11):2724-2736. doi: 10.1161/STROKEAHA.123.044113. Epub 2023 Sep 7. Stroke. 2023. PMID: 37675613 Free PMC article. Clinical Trial.
Intravenous alteplase versus tenecteplase in patients with acute posterior circulation strokes: A secondary analysis from the AcT randomized controlled trial.
Cimflova P, Alhabli I, Bala F, Horn M, Benali F, Buck BH, Catanese L, Coutts PSB, Khosravani H, Appireddy R, Tkach A, Dowlatshahi D, Carpani F, Field T, Hunter G, Hill PMD, Poppe AY, Ademola A, Shamy M, Sajobi TT, Swartz RH, Almekhlafi MA, Menon PBK, Singh N. Cimflova P, et al. Among authors: alhabli i. J Stroke Cerebrovasc Dis. 2024 Nov;33(11):107985. doi: 10.1016/j.jstrokecerebrovasdis.2024.107985. Epub 2024 Aug 31. J Stroke Cerebrovasc Dis. 2024. PMID: 39222700 Clinical Trial.
The treatment effect across ASPECTS in acute ischemic stroke: Analysis from the AcT trial.
Kaveeta C, Alhabli I, Bala F, Horn M, Benali F, Coutts SB, Zafar A, Bereznyakova O, Khaw A, Khosravani H, Hunter G, Tkach A, Dowlatshahi D, Catanese L, Bogiatzi C, Appireddy R, Buck BH, Swartz RH, Sajobi TT, Almekhlafi M, Demchuk AM, Ganesh A, Menon B, Singh N. Kaveeta C, et al. Among authors: alhabli i. Int J Stroke. 2025 Jan;20(1):64-74. doi: 10.1177/17474930241273561. Epub 2024 Sep 11. Int J Stroke. 2025. PMID: 39086232 Free PMC article. Clinical Trial.
Tenecteplase Versus Alteplase in Medium Vessel Occlusion Ischemic Stroke: A Secondary Analysis of the Alteplase Compared to Tenecteplase Randomized Trial.
Bala F, Singh N, Ignacio K, Alhabli I, Ademola A, Alrohimi A, Khosravani H, Tkach A, Catanese L, Dowlatshahi D, Field T, Hunter G, Benali F, Horn M, Demchuk A, Hill M, Sajobi T, Buck B, Swartz R, Almekhlafi M, Menon BK. Bala F, et al. Among authors: alhabli i. J Stroke. 2024 May;26(2):280-289. doi: 10.5853/jos.2023.03713. Epub 2024 May 30. J Stroke. 2024. PMID: 38836275 Free PMC article.
Combining Early Ischemic Change and Collateral Extent for Functional Outcomes After Endovascular Therapy: An Analysis From AcT Trial.
Tanaka K, Kaveeta C, Pensato U, Zhang J, Bala F, Alhabli I, Horn M, Ademola A, Almekhlafi M, Ganesh A, Buck B, Tkach A, Catanese L, Dowlatshahi D, Shankar J, Poppe AY, Shamy M, Qiu W, Swartz RH, Hill MD, Sajobi TT, Menon BK, Demchuk AM, Singh N. Tanaka K, et al. Among authors: alhabli i. Stroke. 2024 Jul;55(7):1758-1766. doi: 10.1161/STROKEAHA.123.046056. Epub 2024 May 24. Stroke. 2024. PMID: 38785076 Clinical Trial.
20 results